Hofseth Biocare expects Atlantic Sapphire JV to soften blow of ongoing losses

Access to raw material is also expected to slow down in the first quarter of 2020.

Hofseth Biocare is still at a loss for Q4 2019. — Hofseth Biocare is still at a loss for Q4 2019.Photo: Hofseth Biocare

Nina Unlay

Published 7 February 2020, 12:47Updated 7 February 2020, 12:47

Hofseth Biocare Atlantic Sapphire